Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Jedamzik

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 2, 2026
Overall Survival with [<sup>177</sup>Lu]Lu-PSMA-617 Versus [<sup>177</sup>Lu]Lu-PSMA I&T: A Propensity Score-Matched Real-World AnalysisNatalie Hasenauer, Charlotte Probst, Wiebke Schloetelburg, et al.
Frontiers in Nuclear Medicine|April 27, 2026
Prognostic impact of discordant lesions on [<sup>18</sup>F]FDG and [<sup>68</sup>Ga]Ga-FAPI-04 PET/CT compared to histological FAP expression in neuroendocrine neoplasmsTim Jedamzik, Aleksander Kosmala, Stefan Kircher, et al.
JMIR Research Protocols|April 29, 2026
Liquid Biopsy Biomarkers in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Prostate-Specific Membrane Antigen Radioligand Therapy: Protocol for a Prospective, Longitudinal Multicenter Observational StudyKerstin Michalski, Theo Lorenzini, Tim Jedamzik, et al.
Cancers|May 14, 2025
Detection of Local Prostate Cancer Recurrence from PET/CT Scans Using Deep LearningMarko Korb, Hülya Efetürk, Tim Jedamzik, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 2, 2026
Overall Survival with [<sup>177</sup>Lu]Lu-PSMA-617 Versus [<sup>177</sup>Lu]Lu-PSMA I&T: A Propensity Score-Matched Real-World AnalysisNatalie Hasenauer, Charlotte Probst, Wiebke Schloetelburg, et al.
Frontiers in Nuclear Medicine|April 27, 2026
Prognostic impact of discordant lesions on [<sup>18</sup>F]FDG and [<sup>68</sup>Ga]Ga-FAPI-04 PET/CT compared to histological FAP expression in neuroendocrine neoplasmsTim Jedamzik, Aleksander Kosmala, Stefan Kircher, et al.
JMIR Research Protocols|April 29, 2026
Liquid Biopsy Biomarkers in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Prostate-Specific Membrane Antigen Radioligand Therapy: Protocol for a Prospective, Longitudinal Multicenter Observational StudyKerstin Michalski, Theo Lorenzini, Tim Jedamzik, et al.
Cancers|May 14, 2025
Detection of Local Prostate Cancer Recurrence from PET/CT Scans Using Deep LearningMarko Korb, Hülya Efetürk, Tim Jedamzik, et al.
Pageof 1